Just got off the phone with the CFO (Craig Carlson) ........
in attempting to verify the story from "Dealreporter" story about the company having hired Goldman Sachs to sell the company between $300 to $400 million. He wouldn't tell me if they hired GS, but he did say they've started the process with regard to possible alternatives. I made the guy mad, but got the information I was looking for, so obviously IMO the company's for sale.
Thanks for the update. I sent an email to TLON's IR better that a week ago and have not received a response, I sort of anticipated that. I asked for an up date of the Menadione trial.
My concern is with a $300 to $400 buy out that may be warranted base on the initial indication for Marqibo but that does not give much of a value to Menadione. Dr. Dietcher said they would like to partner Menadione. I guess we'll have to wait for a CC to find out more.